Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 317Carcinoma, Non-Small-Cell Lung 72Skin Neoplasms 65Carcinoma, Renal Cell 48Lung Neoplasms 45Breast Neoplasms 45Colorectal Neoplasms 42Carcinoma, Basal Cell 41Neoplasms 40Neoplasm Metastasis 40Squamous Cell Carcinoma of Head and Neck 36Uveal Melanoma 33Ovarian Neoplasms 33Carcinoma, Merkel Cell 32Sarcoma 31Lymphoma, T-Cell, Cutaneous 31Pancreatic Neoplasms 26Prostatic Neoplasms 24Head and Neck Neoplasms 22Stomach Neoplasms 21Thyroid Neoplasms 20Urinary Bladder Neoplasms 19Carcinoma, Hepatocellular 19Uterine Cervical Neoplasms 18Esophageal Neoplasms 18Carcinoma, Squamous Cell 18Mycosis Fungoides 16Carcinoma, Transitional Cell 16Brain Neoplasms 16Recurrence 15

Interventions

cemiplimab 1Transdermal Patch 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cutaneous Squamous Cell Carcinoma × Dermatologic × 90 days × Clear all
NCT05377905 2026-04-09

cSCC

University of Pittsburgh

Phase 1/2 Recruiting
48 enrolled
Dermatologic

Cutaneous Squamous Cell Carcinoma

NCT03969004 2026-03-27

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Regeneron Pharmaceuticals

Phase 3 Active not recruiting
415 enrolled 1 FDA
Dermatologic

Cutaneous Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡